Structure and Assembly of the 20S Proteasome
Overview
Authors
Affiliations
The barrel-shaped 20S proteasome is one of the two components of a larger 26S particle, the multicatalytic 2000-kDa protease complex. The proteolytic sites are located in the inner chamber of the 20S particle and are only accessible via narrow entrances. This paper reviews the current knowledge concerning proteasome formation, proteolytic activities, structural aspects and assembly. Eukaryotic proteasomes are made up by four rings each of which contains seven different subunits occurring at fixed positions. While the outer rings contain alpha-type subunits, the inner ones comprise beta-type subunits. The current assembly model for eukaryotic 20S proteasomes is based upon the detection of 13S and 16S intermediates, respectively, in addition to previous findings with archaebacterial and eubacterial proteasome assembly. The available data suggest a cooperative assembly of the alpha-type and beta-type subunits into half proteasome-like complexes followed by dimerization into proteasomes. During or after dimerization of half proteasomes, the beta-type subunits are processed. The prosequence of the beta-type subunits is essential for the assembly proves and prevents protease activity of immature proteasomes.
Copper diethyldithiocarbamate as an activator of Nrf2 in cultured vascular endothelial cells.
Fujie T, Murakami M, Yoshida E, Tachinami T, Shinkai Y, Fujiwara Y J Biol Inorg Chem. 2016; 21(2):263-73.
PMID: 26825804 PMC: 4801994. DOI: 10.1007/s00775-016-1337-z.
From bortezomib to other inhibitors of the proteasome and beyond.
Buac D, Shen M, Schmitt S, Kona F, Deshmukh R, Zhang Z Curr Pharm Des. 2012; 19(22):4025-38.
PMID: 23181572 PMC: 3657018. DOI: 10.2174/1381612811319220012.
Kuhn D, Berkova Z, Jones R, Woessner R, Bjorklund C, Ma W Blood. 2012; 120(16):3260-70.
PMID: 22932796 PMC: 3476538. DOI: 10.1182/blood-2011-10-386789.
Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.
Buac D, Schmitt S, Ventro G, Kona F, Dou Q Mini Rev Med Chem. 2012; 12(12):1193-201.
PMID: 22931591 PMC: 3651834. DOI: 10.2174/138955712802762040.
Screening of potential molecular targets for colorectal cancer therapy.
Honma K, Takemasa I, Matoba R, Yamamoto Y, Takeshita F, Mori M Int J Gen Med. 2010; 2:243-57.
PMID: 20360909 PMC: 2840570. DOI: 10.2147/ijgm.s5158.